ACT Capital Management »

Cyteir Therapeutics shares owned by ACT Capital Management

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $29k 15k 1.93
2022-06-30 $45k 15k 3.00
2022-03-31 $57k 15k 3.80
2021-12-31 $171k 15k 11.40
2021-09-30 $263k 15k 17.53
2021-06-30 $2.0k 90 22.22